Does SUNITINIB MALATE Cause Renal cell carcinoma? 361 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 361 reports of Renal cell carcinoma have been filed in association with SUNITINIB MALATE (Sunitinib malate). This represents 1.7% of all adverse event reports for SUNITINIB MALATE.
361
Reports of Renal cell carcinoma with SUNITINIB MALATE
1.7%
of all SUNITINIB MALATE reports
142
Deaths
135
Hospitalizations
How Dangerous Is Renal cell carcinoma From SUNITINIB MALATE?
Of the 361 reports, 142 (39.3%) resulted in death, 135 (37.4%) required hospitalization, and 21 (5.8%) were considered life-threatening.
Is Renal cell carcinoma Listed in the Official Label?
Yes, Renal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for SUNITINIB MALATE.
What Other Side Effects Does SUNITINIB MALATE Cause?
Death (4,385)
Diarrhoea (3,044)
Fatigue (2,865)
Nausea (2,032)
Neoplasm progression (1,920)
Disease progression (1,745)
Decreased appetite (1,676)
Asthenia (1,651)
Vomiting (1,331)
Dysgeusia (1,226)
What Other Drugs Cause Renal cell carcinoma?
CABOZANTINIB S-MALATE (451)
PAZOPANIB (244)
AXITINIB (154)
RANITIDINE (143)
EVEROLIMUS (130)
SORAFENIB (118)
METHOTREXATE (116)
ADALIMUMAB (105)
PREDNISONE (101)
TACROLIMUS (98)
Which SUNITINIB MALATE Alternatives Have Lower Renal cell carcinoma Risk?
SUNITINIB MALATE vs SUTENT
SUNITINIB MALATE vs SUTIMLIMAB-JOME
SUNITINIB MALATE vs SUVOREXANT
SUNITINIB MALATE vs SUZETRIGINE
SUNITINIB MALATE vs SYMBICORT